collaboration
Open access research partnership to ‘crowdsource’ new myeloma drugs
January 27, 2016Research and Development Myeloma UK, Structural Genomics Consortium, collaboration, eric low, myeloma, partnership
Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to find new drug targets …
Big pharma and UK universities launch £40m innovation fund
January 25, 2016Research and Development, Sales and Marketing Apollo, AstraZeneca, GSK, GlaxoSmithKline, Johnson & Johson, UCL, University College London, University of Cambridge, collaboration, imperial college london, joint venture
A consortium of big pharma companies and university with world-leading medical research facilities is to invest £40 million, to “significantly …
Sanofi seals double oncology research deals
January 11, 2016Research and Development, Sales and Marketing Sanofi, Warp Drive Bio, antibodies, collaboration, immuno-oncology, research
Sanofi has signed two separate research agreements for €1.2 billion, which will give the French firm licensing rights to potential …
Novartis expands immuno-oncology programme
January 11, 2016Research and Development, Sales and Marketing Cancer, Novartis, Surface Oncology, collaboration, immuno-oncology
Novartis has further bolstered its immuno-oncology pipeline through a strategic alliance and licensing agreement with Surface Oncology, as it moves …
ViiV and Janssen to test new HIV regimen in Phase III trial
January 7, 2016Manufacturing and Production, Medical Communications, Research and Development Edurant, HIV, Janssen, ViiV Healthcare, cabotegravir, collaboration, phase III, rilpivirine
Janssen has formalised its collaboration with ViiV Healthcare on the Phase III development and commercialisation of a two-drug regimen to …
Janssen, Enterome and Kymab in research collaborations
January 7, 2016Research and Development Crohn's, Crohn’s disease, Enterome, Janssen, MD Anderson, alliance, antibodies, collaboration, crohn's disease, immuno-oncology, kymab, research
Several pharma companies have announced new collaborations, to research potential new drugs for Crohn’s disease, and immuno-oncology treatments for cancer. …
Ablynx sets focus on pharma collaborations
December 14, 2015Manufacturing and Production, Research and Development Ablynx, collaboration, nanobodies, partnership
Drug development companies should prioritise strategic pharma collaborations to keep up with the next wave of immuno-oncology treatments, the chief …
Merck/Pfizer Alliance to collaborate on late-stage cancer trials
December 10, 2015Research and Development Merck, Pfizer, avelumab, collaboration, gastric cancer, oncology, partnership, stomach cancer
Merck and Pfizer are partnering to run two Phase III trials of avelumab, an immuno-oncology treatment the companies hope to …
The age of collaboration: why pharma companies now have to work together
December 9, 2015Research and Development R&D, co-operation, collaboration, pharma
It seems 2015 may be remembered as the year of the mega merger; the year when all records were broken …
Teva and Heptares enter $400m agreement for small-molecule migraine treatment
November 25, 2015Research and Development Heptares, Teva, collaboration, migraine
Teva Pharmaceuticals and Heptares Therapeutics have signed a licensing and drug-discovery agreement for Teva to gain exclusive global rights to …
Bristol-Myers Squibb in new oncology collaboration
November 25, 2015Research and Development Bristol-Myers Squibb, collaboration, immuno-oncology, investment, venture capital
Bristol-Myers Squibb and European healthcare fund Life Sciences Partners are forming a strategic collaboration to identify breakthrough technologies. The companies …
Merck and Selvita form oncology partnership
November 2, 2015Research and Development, Sales and Marketing Merck, Selvita, collaboration, oncology
Merck has entered a three-year agreement with Selvita to validate new therapeutic concepts in the field of oncology. The aim …
Cambridge collaboration to boost precision medicine research
July 29, 2015Research and Development Brabaham Institute, Cambridge, R&D, collaboration
A new consortium has been launched to act as a ‘match-making’ service between pharma companies and R&D researchers to develop …
Sanofi and Regeneron in immuno-oncology push
July 28, 2015Manufacturing and Production, Research and Development Cancer, PD-1 inhibitors, Regeneron, Sanofi, collaboration, immuno-oncology, pd-1
Pharma giants Sanofi and Regeneron are extending the partnership that brought new heart drug Praluent to the market, with a …
Pharma outsourcing: CROs, CMOs and external collaboration
July 2, 2015Manufacturing and Production, Research and Development CMOs, R&D, clinical trials, collaboration, cros, outsourcing
Thirty years ago pharma companies seemed to use external contractors as a sort of fire brigade, to be called in …
Latest content
Five Facts about cardiovascular disease
